Clinical trials
Neuroblastoma trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hadassah Medical Organization | 2 |
| St. Anna Kinderkrebsforschung | 2 |
| Children's Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Genzyme, a Sanofi Company | 1 |
| Instituto de Investigacion Sanitaria La Fe | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Shaare Zedek Medical Center | 1 |
| University of Leicester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 12 |
| Burkitt Lymphoma | 3 |
| Recurrence | 3 |
| Sarcoma | 3 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
| Glioblastoma | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.